News
People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.
Tradicionalne velikonočne jedi so preverjeno odlične, toda naše brbončice hrepenijo po novih okusih, teksturah in ...
The Gourdie laboratory had a problem of its own making. The lab at the Fralin Biomedical Research Institute at VTC has spent years exploring how microscopic containers naturally found in raw cow's ...
- Vzemimo za ilustracijo Trumpovo lomastenje po mednarodni skupnosti. Kot tipičen primerek narcisistične osebnostne strukture ...
Odziv Evropske unije na odločitev ameriškega predsednika Donalda Trumpa, da uvede tako imenovane vzajemne carine vsem ...
Trump je v prvem mandatu na kitajsko blago uvedel povprečno carinsko stopnjo 19,3 odstotka. Bidenova administracija je ohranila večino Trumpovih carin in dodala nove, kar je povprečno stopnjo dvignilo ...
Ta prazna poljana, na kateri si moja Črnogorčka umažeta čevlje, saj se jima do šole in nazaj ne da hoditi okrog nje, meri ...
Ni redko, da se najde slovenski podjetnik, ki javno ali v zasebnem pogovoru pove, kako pameten in blagodejen je predsednik ...
In trading on Friday, shares of Mesoblast Ltd (Symbol: MESO) entered into oversold territory, hitting an RSI reading of 28.7, after changing hands as low as $12.20 per share. By comparison ...
School of Environmental Science and Engineering, Shanghai Jiao Tong University, Shanghai 200240, China State Key Laboratory of Hydraulics and Mountain River Engineering, College of Architecture and ...
Last Saturday, teenager Karabo Meso added her name to the honours list at the University of Pretoria by entertaining all and sundry with her vast range of strokes to raise her bat for the maiden ...
Still, it's fun to speculate a bit, at least until we know more about Z-A's ultimate plans and how it will earn that bump-up in the E range. Pokémon Legends: Z-A is slated for a late 2025 launch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results